Overexpression of p53 protein and histologic grades of dysplasia in colorectal adenomas

Diseases of the Colon and Rectum

Volumn 39, Issue 5, 1996, Pages 562-567

  Sameshima, Shinichi ^a   Kubota, Yoshiro ^b   Sawada, Toshio ^a   Watanabe, Toshiaki ^a   Kuroda, Toshihiko ^a   Tsuno, Nelson ^a   Higuchi, Yoshiki ^a   Shinozaki, Masaru ^a   Sunouchi, Koki ^a   Masaki, Tadahiko ^a   Saito, Yukio ^a   Muto, Tetsuichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Kikkoman General Hospital   (Japan)

Author keywords

Adenoma carcinoma sequence; Colorectal adenoma; Colorectal carcinoma; Dysplasia; Immunohistochemistry; p53

Indexed keywords

PROTEIN P53;

ADVANCED CANCER; CLINICAL ARTICLE; COLON ADENOMA; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DYSPLASIA; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; RECTUM ADENOMA; TUMOR SUPPRESSOR GENE;

EID: 9344242400     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02058712     Document Type: Conference Paper

References (35)

1. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975;36:2251-70.
2. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Cho KR, Vogelstein B. Genetic alterations in the adenoma-carcinoma sequence. Cancer 1992;70:1727-31.
5. Lane DP, Crawford LV. T Antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278: 261-3.
6. Benchimol S, Lamb P, Crawford LV, et al. Transformation associated p53 protein is encoded by a gene on human chromosome 17. Somat Cell Mol Genet 1985;11: 505-10.
7. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumour antigen to band 17p13. Nature 1986;320:84-5.
8. McBride OW, Merry D, Givol D. The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm(17p13). Proc Natl Acad Sci USA 1986;83: 130-4.
9. Lane DP, Benchimol S. p53: Oncogene or antioncogene? Genes Dev 1990;4:1-8.
10. Eliyahu D, Raz A, Gruss P, Givol D, Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature 1984;312:646-9.
11. Parada LF, Land H, Weinberg RA, Wolf D, Rotter V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 1984;312: 649-51.
12. Jenkins JR, Rudge K, Currie GA. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature 1984;312: 651-4.
13. Hinds P, Finlay C, Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol 1989;63:739-46.
14. Eliyahu D, Goldfinger N, Pinhasi KO, et al. Meth A fibrosarcoma cells express two transforming mutant p53 species. Oncogene 1988;3:313-21.
15. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 1988;8: 531-9.
16. Nigro JM, Baker SJ, Preisinger AC, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
17. Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990;335:675-9.
18. Bartek J, Iggo R, Gannon J, Lane DP. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 1990;5:893-9.
19. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-5.
20. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
21. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-8.
22. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH. Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Naaire 1990;348:747-9.
23. Milner J, Medcalf EA, Cook AC. Tumor suppressor p53: analysis of wild-type and mutant p53 complexes. Mol Cell Biol 1991;11:12-9.
24. Cunningham J, Lust JA, Schaid DJ, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992;52:1974-80.
25. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors: an immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol 1992;140:145-53.
26. van den Berg FM, Tigges AJ, Schipper ME, den Hartog-Jager FC, Kroes WG, Walboomers JM. Expression of the nuclear oncogene p53 in colon tumours. J Pathol 1989; 157:193-9.
27. Rodrigues NR, Rowan A, Smith ME, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990;87: 7555-9.
28. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991;138: 807-13.
29. Kawasaki Y, Monden T, Morimoto H, et al. Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. Am J Clin Pathol 1992;97:244-9.
30. Morson BC, Jass JR. Precancerous lesions of the gastrointestinal tract. London: Bailliere Tindall, 1985:10.
31. Jass JR, Sobin LH. Histological typing of intestinal tumours. 2nd ed. Berlin: Springer-Verlag, 1989:29-32.
32. Gannon JV, Greaves R, Iggo R, Lane DP. Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J 1990;9:1595-602.
33. Cook A, Milner J. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein. Br J Cancer 1990;61:548-52.
34. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991;63: 317-9.
35. Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992;50:683-8.